Literature DB >> 446751

Synthesis and degradation of collagen by skin fibroblasts from controls and from patients with osteogenesis imperfecta.

B U Steinmann, G R Martin, B I Baum, R G Crystal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446751     DOI: 10.1016/0014-5793(79)81023-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  7 in total

1.  Disturbances in collagen synthesis in trisomic cells from spontaneously aborted embryos.

Authors:  V I Kukharenko; A A Delvig; K N Grinberg
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Tissue specificity of type I collagen gene expression is determined at both transcriptional and post-transcriptional levels.

Authors:  R J Focht; S L Adams
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

3.  Osteogenesis imperfecta: biochemical and clinical evaluation of 13 cases.

Authors:  T Krieg; E Kirsch; K Matzen; P K Müller
Journal:  Klin Wochenschr       Date:  1981-01-15

4.  Synthesis of glycosaminoglycans and collagen in skin fibroblasts cultured from a patient with lichen myxedematosus.

Authors:  H Turakainen; M Välimäki; R Penttinen
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  Altered glycosaminoglycan production in cultured osteogenesis-imperfecta skin fibroblasts.

Authors:  H Turakainen
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

6.  Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.

Authors:  G S Barsh; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide.

Authors:  L Peltonen; A Palotie; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.